Drug intelligence / Profile preview

diwuyanggan

Development stage
Unknown
Lead developer
Hubei University of Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Diwuyanggan (DWYG) is a traditional Chinese medicine (TCM) prescription formulated as a hospital preparation and authorized drug in China. It consists of five herbal extracts in specific proportions by weight: Rehmannia glutinosa (20%), Artemisia scoparia (33.3%), Curcuma longa (13.4%), Schisandra chinensis (20%), and Glycyrrhiza uralensis (13.4%)[6][1]. DWYG has been studied for its effects on liver diseases, including hepatitis and hepatocellular carcinoma, with reported activities such as regulating liver regeneration, modulating immune responses, ameliorating liver injury and fibrosis, antiviral effects, and suppressing hepatic cancer[6][8][2]. Mechanistically, it appears to act through modulation of the hepatic stem cell microenvironment and regulation of signaling pathways such as Ras/Raf/Mek/Erk[9], reversing gene expression changes associated with liver injury or cancer[8]. Over 200 compounds have been identified within the formulation using advanced mass spectrometry techniques[8].

Brand names
Diwu YangganDiWuYangGanDiwu Yanggan capsule
Other names
DWYGDiWuYangGan capsule

Beyond the preview

Go deeper on diwuyanggan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diwuyanggan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call